BALCAO · LABORATORY ANALYTICAL INSTRUMENTS · SMALL CAP
Scientific Industries, Inc. SCND
15 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$5.1M
▲ 5.4% vs FY2024
EPS · FY25
$-0.11
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-12.3%
Net margin · FY25
-24.1%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 5.1M
Revenue, FY2025 · full 15-year series below
Revenue
Net income
The company lost 24 cents on every revenue dollar this year.
Per share
USD -0.11
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-12.3%
Return on equity, FY2025
ROE
Operating margin-156.1%
Net margin-24.1%
Return on assets-10.1%
Each USD of equity lost 12 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
−12.4% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−12.4%
−6.2%
−1.0%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.01B
Shares outstanding, FY2025
Change, 5 years+84.7%
Change, 10 years—
The share count grew 85% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 12.6M
total assets, end of FY2025
Total assetsUSD 12.6M
EquityUSD 10.7M
CashUSD 955,000.00
Current ratio7.70×
Equity funds 85% of total assets.
History
15 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
0.0
−0.0
−0.0
0.0
0.0
0.0
EBITDA $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Income tax $B
0.0
0.0
0.0
0.0
−0.0
−0.0
0.0
0.0
−0.0
0.0
−0.0
−0.0
0.0
−0.0
0.0
Net income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
0.0
0.0
−0.0
0.0
0.0
0.0
EPS, diluted $
−0.11
−0.61
−1.27
·
−1.00
−0.46
0.43
−0.11
−0.05
0.11
0.01
−0.05
0.30
0.05
0.19
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
90
47
ROE %
−12.3
−56.0
−65.4
−62.5
−19.4
−7.8
10.7
−2.8
−1.2
2.8
0.2
−1.4
7.6
1.4
4.9
Shares out B
0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
58 of 59
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 1 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed